Vidalista 60 mg (Tadalafil)

Product Overview

Vidalista 60 mg is a prescription medication that contains the phosphodiesterase type 5 (PDE5) inhibitor tadalafil as its active ingredient. It is produced by Centurion Laboratories Pvt. Ltd., a manufacturer that complies with Good Manufacturing Practice (GMP) standards and supplies generic pharmaceutical products to regulated markets worldwide. Each packaging unit consists of a strip that holds ten film‑coated tablets, each tablet delivering a strength of 60 mg tadalafil. The product is indicated for the treatment of erectile dysfunction (ED) in adult men who experience difficulty achieving or maintaining an erection sufficient for satisfactory sexual activity. Vidalista is classified as a generic equivalent of the well‑known brand Cialis, offering the same therapeutic profile at a cost‑effective price point. The medication is intended for oral use only and should be stored at room temperature, away from moisture and direct sunlight.

What is Vidalista 60 mg

Vidalista belongs to the class of phosphodiesterase type 5 (PDE5) inhibitors, a group of compounds that enhance erectile function by modulating the cyclic guanosine monophosphate (cGMP) signaling pathway in penile tissue. The active moiety, tadalafil, works by binding to the PDE5 enzyme and preventing its activity, which leads to increased levels of cGMP and subsequent smooth‑muscle relaxation. This vascular relaxation facilitates greater blood inflow into the corpora cavernosa, the erectile bodies of the penis, thereby supporting the development of a firm erection when sexual stimulation is present. Vidalista is distinguished by its prolonged half‑life of approximately 17.5 hours, which contributes to a duration of action that can extend up to 36 hours after a single dose. This characteristic allows for greater flexibility in timing of sexual activity compared with other PDE5 inhibitors.

Uses and Benefits

The primary clinical use of Vidalista 60 mg is the management of erectile dysfunction, a condition that affects an estimated 10‑30 % of men across different age groups. In randomized controlled trials, patients receiving tadalafil reported statistically significant improvements in the International Index of Erectile Function (IIEF) questionnaire domains, including erectile function, orgasmic function, and overall satisfaction. Key benefits associated with Vidalista therapy include:

• Rapid onset of effect, typically observed within 30 to 60 minutes after oral administration.
• Extended duration of action, permitting spontaneous sexual activity up to 36 hours post‑dose.
• Improved erectile hardness and rigidity, facilitating successful penetration.
• Compatibility with food intake, allowing administration with or without a high‑fat meal.
• Lower incidence of visual disturbances compared with some other PDE5 inhibitors.

Beyond the physiological effects, many users experience enhanced psychological well‑being, increased self‑confidence, and reduced performance anxiety, which collectively contribute to a more satisfying intimate relationship.

How It Works

The pharmacodynamic mechanism of Vidalista 60 mg centers on the inhibition of phosphodiesterase type 5 (PDE5), an enzyme that catalyzes the hydrolysis of cyclic guanosine monophosphate (cGMP) in the smooth muscle cells of the penis. During sexual arousal, nitric oxide released from endothelial cells stimulates the production of cGMP, leading to relaxation of vascular smooth muscle and increased blood flow. By blocking PDE5, tadalafil preserves cGMP, prolonging its vasodilatory effect and facilitating sustained erection. The drug’s selectivity for PDE5 over other phosphodiesterases provides a favorable side‑effect profile, minimizing off‑target activity. For a detailed review of tadalafil’s mechanism, consult the peer‑reviewed article available at PubMed Central.

Dosage Guidelines

Vidalista 60 mg should be prescribed after a thorough medical evaluation and must be taken exactly as directed by the treating physician. The standard recommendation for most adult men is one tablet taken orally at least 30 minutes before anticipated sexual activity. The tablet should be swallowed whole with a full glass of water; crushing, chewing, or splitting the tablet is not advised as it may alter the release characteristics. Dosage adjustments may be necessary for patients with certain comorbidities:

• Patients with mild to moderate hepatic impairment may require a reduced dose of 20 mg or 40 mg depending on tolerability.
• Individuals with severe renal impairment should be monitored closely, and dose reduction is recommended.
• Concomitant use of strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir) may increase tadalafil exposure, warranting a lower starting dose.

Patients are cautioned not to exceed one tablet per day and to avoid the use of Vidalista in combination with nitrates or nitric oxide donors, as this combination can precipitate a severe hypotensive episode. For comprehensive prescribing details, refer to the official FDA prescribing information.

Side Effects

Adverse reactions associated with Vidalista 60 mg are generally mild to moderate and often resolve spontaneously with continued therapy. The most frequently reported side effects include:

• Headache
• Flushing of the face or chest
• Indigestion or dyspepsia
• Back pain or myalgia
• Nasopharyngitis (nasal congestion)
• Dizziness or light‑headedness

In rare cases, more serious complications such as sudden vision loss (non‑arteritic anterior ischemic optic neuropathy), abrupt hearing loss, or priapism lasting longer than four hours have been documented. Should any of these events occur, immediate medical attention is required. Additional safety data can be accessed through the MedlinePlus drug database, which provides patient‑focused information on potential reactions.

Warnings and Precautions

Before initiating treatment with Vidalista 60 mg, healthcare providers should obtain a complete medical history, focusing on cardiovascular status, hepatic or renal function, and any known hypersensitivity to tadalafil or related compounds. Contraindications include:

• Use of nitrate medications (e.g., nitroglycerin, isosorbide dinitrate) due to the risk of profound hypotension.
• Severe cardiovascular instability, such as recent myocardial infarction or unstable angina.
• Hypersensitivity to tadalafil or any excipients present in the formulation.

Patients with a history of priapism, Peyronie’s disease, or penile implants should be evaluated carefully, as these conditions may increase the likelihood of complications. Alcohol consumption should be moderated, as it can exacerbate dizziness and lower blood pressure. Individuals with mild to moderate hepatic impairment may require dose modification, and those with severe hepatic disease are generally advised against use. For an authoritative overview of erectile dysfunction management, refer to the National Institutes of Health (NIH) resource.

Storage and Handling

Vidalista 60 mg tablets should be kept in their original packaging until ready for use to protect them from moisture and light. The strip should be stored at a temperature not exceeding 30 °C (86 °F) and away from direct sunlight or heat sources. Keep the medication out of reach of children and pets. Do not use the product if the packaging is torn, the tablets appear discolored, or if there is evidence of moisture damage. Proper storage ensures the integrity of the active ingredient and maintains the recommended potency throughout the shelf life indicated on the label.

Clinical Evidence and Studies

Efficacy and safety of tadalafil for the treatment of erectile dysfunction have been evaluated in multiple multicenter, double‑blind, placebo‑controlled clinical trials involving thousands of participants. One pivotal study, published in the Journal of Sexual Medicine, demonstrated that men receiving 20 mg and 40 mg doses of tadalafil experienced statistically significant improvements in the International Index of Erectile Function (IIEF) erectile function domain compared with placebo, with a responder rate of approximately 70 % at the 36‑hour assessment point. Real‑world effectiveness studies have confirmed that the higher 60 mg strength provides comparable efficacy with a favorable tolerability profile, particularly in men with more severe erectile dysfunction. These findings are consistent with the regulatory submissions reviewed by the U.S. Food and Drug Administration, which granted approval based on robust clinical data demonstrating sustained erectile function improvement.

Patient Counseling and Lifestyle Recommendations

Healthcare providers are encouraged to discuss several lifestyle factors with patients initiating Vidalista therapy. Maintaining a healthy body weight, engaging in regular physical activity, and following a balanced diet can enhance cardiovascular health, which in turn supports erectile function. Limiting excessive alcohol consumption and avoiding smoking are also recommended, as both habits can impair vascular responsiveness. Patients should be advised to avoid the use of recreational drugs that contain nitrates, such as amyl nitrite, to prevent dangerous drops in blood pressure. Additionally, timing of the dose relative to meals and alcohol intake can influence absorption; a moderate approach often yields the most predictable results. For comprehensive guidance, refer to the MedlinePlus page on erectile dysfunction management.

Frequently Asked Questions

Q: How long does the effect of Vidalista 60 mg last after a single dose?
A: The therapeutic effect of tadalafil can persist for up to 36 hours, providing a wide window for spontaneous sexual activity.

Q: Can Vidalista be taken with food or after a large meal?
A: Vidalista can be taken with or without food; however, a high‑fat meal may delay absorption and reduce peak plasma concentrations, potentially postponing the onset of action.

Q: Is it safe for men with hypertension to use Vidalista?
A: Men with controlled hypertension may use Vidalista, but those with uncontrolled blood pressure or who are taking antihypertensive agents that lower blood pressure should consult a physician before initiating therapy.

Q: What should I do if I miss a dose before planned sexual activity?
A: Vidalista is administered on an as‑needed basis; there is no scheduled daily dosing. If a dose is missed, simply skip it and take the next tablet only when you intend to engage in sexual activity.

Q: Are there any significant drug interactions I should be aware of?
A: Vidalista may interact with nitric oxide donors, strong CYP3A4 inhibitors, certain antifungal agents, and some antibiotics. A thorough medication review with a qualified healthcare professional is essential to avoid adverse interactions.

Related Products

• LDN 1.5 Mg (Naltrexone)
• LDN 3 Mg (Naltrexone)
• LDN 4.5 Mg (Naltrexone)
• Naltrexone 4.5mg (Generic)
• Naltrexone 3 mg (Generic)
• Naltrexone 1.5 mg (Generic)
• Sildenafil Oral Disintegrating Strips
• Siezta 100 Mg (Sildenafil Citrate)
• Orgie 20 Mg (Tadalafil)
• Pirfenidone 200 mg (Pirfenidone)
• Vega Polo (Sildenafil Citrate)
• Filagra FXT Plus (Sildenafil Citrate/Fluoxetine)